← Back to list
05.00.74l, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies
Effective date
Dec 29, 2025
Identified
Oct 29, 2026
Summary
Independence Blue Cross reissued medical policy 05.00.74l on 10/28/2026 with no substantive changes to TENS device coverage criteria. The policy clarifies medically necessary criteria for chronic pain (other than lower back pain) and experimental/investigational criteria. A prior change effective 12/29/2025 removed a specific pain reduction threshold requirement (50% reduction) from continued coverage criteria. This is a reissue communicating the company's continuing position; verify current applicability for your practice's active plans.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.
Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.
What to do
Action · 3 steps
01Already effective 12/29/2025: Verify whether the practice has implemented the substantive changes from the 12/29/2025 version of policy 05.00.74l, specifically the removal of the '50% reduction in pain' requirement from the continued coverage criteria for chronic TENS therapy.
02Billing staff should confirm that prior authorization workflows for TENS devices (E0720, E0730) and supplies (A4556, A4557, A4558, A4595, A4630) align with current medically necessary criteria: (1) for chronic pain trials, document the 30–60 day trial period with provider monitoring and likelihood of significant therapeutic benefit for continued coverage; (2) ensure rental reimbursement during trial and purchase reimbursement after successful trial; (3) verify supply utilization limits are enforced (A4595: max 1 unit/month for 2-lead, 2 units/month for 4-lead; A4557: once per 12 months).
03The 10/28/2026 reissue confirms no new changes; however, check current applicability with Independence Blue Cross to ensure all effective-date requirements remain valid for your contracted plans.
Codes mentioned
E0720E0730A4556A4557A4558A4595A4630G89.12G89.18G89.21G89.29G89.3G89.4
Original notice
05.00.74l, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies
medpolicy.ibx.com · Always check the source before changing claims.
Related changes
See all Independence Blue Cross changes →MA05.006l, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated SuppliesMediumEffective Dec 29, 2025 · Medical PolicyMA05.006k, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated SuppliesMediumEffective Oct 1, 2025 · Medical Policy05.00.74k, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated SuppliesLowEffective Oct 1, 2025 · Medical Policy05.00.74l, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated SuppliesMediumEffective Dec 29, 2025 · Medical PolicyBrowse every Independence Blue Cross change in the policy list